Top compounds associated with response to CDC73


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC -0.22 0.002
mRNA gossypol CTRPv2 pan-cancer AAC 0.11 0.003
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.098 0.003
mRNA LY317615 GDSC1000 pan-cancer AAC 0.097 0.004
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.085 0.007
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.007
Download CSV